Autoimmune аnti-NMDA encephalitis associated with the new coronavirus infection COVID-19
- 2 October 2023
- journal article
- research article
- Published by Medical Informational Agency Publishers in Russian neurological Journal
- Vol. 28 (4) , 60-67
Abstract
The article presents a clinical case of a 19-year-old patient with reliable autoimmune anti-NMDA encephalitis, developed after a coronavirus infection, which was accompanied by the signs of catatonia, epilepsy and mutism at the onset of the disease. This case enlarges the statistics of observations of this pathology by including the SARS-COV 2 virus to the list of possible etiological factors. The analysis of the catatonia signs, dominating at the onset of the disease, was carried out.Keywords
This publication has 57 references indexed in Scilit:
- Catatonia in DSM-5Schizophrenia Research, 2013
- Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort studyThe Lancet Neurology, 2013
- Paraneoplastic neurological syndromesCurrent Opinion in Neurology, 2012
- Extreme delta brushNeurology, 2012
- Anti-NMDA-Receptor Encephalitis: Case Report and Literature Review of an Under-Recognized ConditionJournal of General Internal Medicine, 2011
- Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitisThe Lancet Neurology, 2011
- Anti-NMDA receptor encephalitis: report of ten cases and comparison with viral encephalitisEuropean Journal of Clinical Microbiology & Infectious Diseases, 2009
- Paraneoplastic anti–N‐methyl‐D‐aspartate receptor encephalitis associated with ovarian teratomaAnnals of Neurology, 2007
- Paraneoplastic encephalitis, psychiatric symptoms, and hypoventilation in ovarian teratomaAnnals of Neurology, 2005
- Catatonia. I. Rating scale and standardized examinationActa Psychiatrica Scandinavica, 1996